Biotechnology
A New Nanocluster Technology to Treat Metal-Related Disorders
PHOREXA is a biotech spin-off from academic research developing a breakthrough metal nanocluster technology with the potential to transform the treatment of metabolic diseases.
By enabling essential metals to reach target organs while bypassing physiological barriers and impaired or blocked metal transporters, our technology opens new therapeutic possibilities for diseases where conventional metal transport mechanisms fail.
Follow us:
Start a conversation
For research partnerships, investment enquiries, or shared ideas, we would love to hear from you.
Your details are used only to respond to your enquiry.